Publications:

Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018.

Emerging Infectious Diseases

Won, Eun Jeong EJ; Choi, Min Ji MJ; Kim, Mi-Na MN; Yong, Dongeun D; Lee, Wee Gyo WG; Uh, Young Y; Kim, Taek Soo TS; Byeon, Seung Ah SA; Lee, Seung Yeob SY; Kim, Soo Hyun SH; Shin, Jong Hee JH

Publication Date: 2021-03

Variant appearance in text: MSH2: S316I

PubMed Link: 33624581

Variant Present in the following documents:

• Main text
• 20-3482.pdf

View BVdb publication page

Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.

Mycoses

Arastehfar, Amir A; Daneshnia, Farnaz F; Salehi, Mohammadreza M; Yaşar, Melike M; Hoşbul, Tuğrul T; Ilkit, Macit M; Pan, Weihua W; Hagen, Ferry F; Arslan, Nazlı N; Türk-Dağı, Hatice H; Hilmioğlu-Polat, Süleyha S; Perlin, David S DS; Lass-Flörl, Cornelia C

Publication Date: 2020-09

Variant appearance in text: MSH2: S316I

PubMed Link: 32413170

Variant Present in the following documents:

• Main text
• MYC-63-911.pdf

View BVdb publication page

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance.

Nature Communications

Healey, Kelley R KR; Zhao, Yanan Y; Perez, Winder B WB; Lockhart, Shawn R SR; Sobel, Jack D JD; Farmakiotis, Dimitrios D; Kontoyiannis, Dimitrios P DP; Sanglard, Dominique D; Taj-Aldeen, Saad J SJ; Alexander, Barbara D BD; Jimenez-Ortigosa, Cristina C; Shor, Erika E; Perlin, David S DS

Publication Date: 2016-03-29

Variant appearance in text: MSH2: S316I

PubMed Link: 27020939

Variant Present in the following documents:

• Main text
• ncomms11128.pdf

View BVdb publication page